Re: 6%

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 6%

in response to

KayakerBC

posted on Dec 14, 2022 03:46PM

"I wonder if they created ZE to limit what gets distributed to ZCC and to shareholders."

think u nailed it & belive we will find out sooner than later - your not the only ones whos been "wary of the company struture"

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply